Physician profile
Heather Minshew
NPI 1861820987
$1,026.16
in general payments reported to CMS, 2019-2025
17 companies · $33.19 in 2025
The $33.19 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $555 · 2022: $174 · 2023: $75.74 · 2024: $189 · 2025: $33.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mallinckrodt Hospital Products INC. | $208.69 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $152.18 | 2021-2025 | Breztri |
| Lilly USA, LLC | $139.54 | 2022-2024 | Mounjaro, Zepbound |
| Abbvie INC. | $104.54 | 2023-2024 | |
| Opko Pharmaceuticals, LLC | $80.55 | 2021 | |
| Alexion Pharmaceuticals, INC. | $57.07 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $47.58 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $38.62 | 2021 | |
| Aurinia Pharma U.S., INC. | $33.72 | 2022 | |
| Novo Nordisk INC | $28.64 | 2022-2023 | Wegovy |
| Novartis Pharmaceuticals Corporation | $21.88 | 2022 | |
| Amgen INC. | $21.23 | 2023 | Repatha |
| Vifor Pharma, INC. | $19.62 | 2021 | |
| Abbott Laboratories | $19.44 | 2025 | Freestyle Libre |
| Paratek Pharmaceuticals, INC. | $17.96 | 2023 | Nuzyra |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $17.89 | 2021 | |
| Fresenius USA Marketing, INC. | $17.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Minshew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.